Follow The Filings

IMA ImageneBio

ImageneBio earnings company data as of 4:47 AM ET 10/24

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 11 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by IMA's executives, directors and 10% owners in the last 12 months, from their Form 4s

All IMA insider trades
  • $96K bought by 1 insider
  • $17K sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Robert B Lally Principal Accounting Officer
    Sale
    $17K 3,196 shares at $5.42 5.4% of stake
    Traded Jul 16–17 Filed Jul 20
    ↗
  2. Joseph P Slattery Director
    Buy
    $96K 16,000 shares at $5.99 New stake
    Traded Dec 24, 2025 Filed Dec 29, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 5 stock grants, 1 other transaction, and 1 option exercise.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
424B3 Filing Doc
8-K 5.02,8.01,9.01 Filing Doc
424B3 Filing Doc
424B3 Filing Doc
8-K 5.02 Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
424B3 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
424B3 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
424B3 Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
SCHEDULE 13D/A — Filing Doc
SCHEDULE 13D — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 1.01,3.02,9.01 Filing Doc
424B3 Filing Doc
8-K 5.02 Filing Doc
8-K 2.02,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 7 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.